Tuesday, November 25, 2025

Faced with Medicaid Reimbursement Cutbacks All 50 states file applications for $50B rural health fund: CMS




All 50 states file applications for $50B rural health fund: CMS

The five-year fund will prioritize investment proposals that bring lasting benefits to rural health providers and tackle "the root causes of rural healthcare failure," officials said. That means workforce recruitment, new pay models, advanced technology adoption and more, though some restrictions will apply. ((Getty/OgnjenO))

All 50 states have filed their bids for a greater share of the five-year, $50 billion Rural Health Transformation Program by Wednesday's deadline, the Centers for Medicare & Medicaid Services (CMS) announced Thursday morning. 


The fund, authorized this summer under the One Big Beautiful Bill Act, will allocate $10 billion annually between fiscal years 2026 and 2030. Half the money will be split evenly, with the remaining half distributed by CMS based on how well states' pitches met its goals of strengthening rural health prevention, standing up sustainable access, developing a rural workforce and introducing innovative care delivery and technology. 

The application process has been tight for applicants and CMS alike. The administration had about two months to put together the program and from the bill's signing to the Sept. 15 opening for applications (see more on that below the break). States, meanwhile, had less than two months from that point to review CMS' final Notice of Funding Opportunity, engage stakeholders and put their pitches into writing.

CMS said it will be announcing the approved awardees by Dec. 31, with the funds to begin flowing on Oct. 1, 2026. Application review will be conducted by federal and nonfederal experts with oversight from senior federal review directives, CMS said, with officials previously noting that some reviews would be recused from judging applications from their home state in order to ensure fairness. 

CMS Administrator Mehmet Oz, M.D., who spoke about the program Thursday morning at the Milken Institute's Future of Health Summit 2025, described the program as an unprecedented uptick in federal funding for rural health providers. He noted that about 7% of total Medicaid money, or about $19 billion per year, goes to rural America, and that another $10 billion per year under the fund would represent a nearly 50% annual increase.

The uptick, he said, is "transformative and will allow us to right-size the healthcare system in all kinds of innovative ways—and many of those innovations will spill over to suburban and urban America as well. We figure out better ways ... to use telemedicine more effectively, to improve working conditions, so that you can recruit more people in the healthcare space or train more nurses. All these spill over to help the entire healthcare system."

State health department heads have previously shared similar optimism for the program, though industry stakeholders have noted it comes as providers are facing permanent cuts to federal Medicaid funding also brought about by the One Big Beautiful Bill Act. Those cuts are estimated to reach nearly $1 trillion over the next decade.


CMS opens state applications for $50B Rural Health Transformation Program 

Sept. 15, 2025

The Centers for Medicare & Medicaid Services (CMS) has opened up state applications for the five-year, $50 billion Rural Health Transformation Program intended to blunt, in part, upcoming cuts to hospitals’ Medicaid funding.

The hotly anticipated fund was authorized by the summer’s One Big Beautiful Bill Act, allocating $10 billion each fiscal year between fiscal year 2026 and 2030. Under the statute, half of the money will be distributed equally among all approved states with the remaining half flowing at the CMS’ discretion with the broad goal of strengthening rural providers and communities.

States may now access a Notice of Funding Opportunity to apply for the program before the Nov. 5 deadline, with the CMS announcing awardees by Dec. 31.

Details on what must be included in the applications, how the office will be grading received applications and specific restrictions on how the funds may be used are outlined in a new FAQ (PDF) and the Notice of Funding Opportunity’s full documentation.

“Rural healthcare deserves a healthcare system built for rural reality, not an afterthought of urban leftovers,” Department of Health and Human Services Secretary Robert F. Kennedy Jr. said Monday in a video announcement. “Right now, only 7% of Medicaid hospital spending reaches rural hospitals. That’s got to change. The Rural Healthcare Transformation Program is that change.”

President Donald Trump and Republicans' sweeping legislation signed into law July 4 will reduce federal Medicaid funding by nearly $1 trillion over the next decade and is estimated to lead to nearly 10 million people going without insurance by 2034.

Lawmakers debating the bill grappled with warnings from industry and constituents that the limits on healthcare funding mechanisms (such as provider taxes) could strangle financially struggling hospitals, particularly those in rural areas. In response, the $50 billion rural fund was added to push the bill over the finish line.

Hospital groups and even some of the bill’s cosigners have described the fund as insufficient compared to the bill’s coming cuts, and legislation has been proposed to bump the total up to $100 billion.

Earlier this month, the National Rural Health Association and Manatt Health released an analysis (PDF) projecting that the $50 billion fund would only address a maximum of 88% of the bill’s Medicaid cuts—assuming 100% of the funds be directed solely to rural hospitals and not other healthcare providers being hit with the reductions. Meanwhile, researchers have warned that urban hospitals and health systems have increasingly obtained rural facility Medicare designations that allow these organizations to apply to rural reimbursement programs while maintaining urban hospital benefits.

The CMS’ FAQ notes there are “no specific restrictions in the [Notice of Funding Opportunity] on which provider organizations can effectuate impact on rural communities and residents,” such as a requirement that funded providers be located in rural areas.


Application requirements, funding limitations aim for "sustainable impact"
 

The agency broadly outlined five strategic goals for the $50 billion program: to “make rural America healthy again” by promoting preventive care and addressing chronic disease management; to improve rural providers’ efficiency and sustainability; to attract and retain healthcare workers for rural communities (with required five-year service commitments); to develop and implement innovative payment models; and to fund greater access to digital tools, remote care and other technologies.

“The program tackles the root causes of rural healthcare failure,” RFK Jr. said. “It gives states the tools to design solutions that last—not Band-Aids that fail.”

On a more granular level, states’ applications must outline a plan to use program funds for at least three of out 11 specific permissible uses (nine as specified by statute and two others “as determined by the Administrator”).

Among these are investments into “significant IT technology advances,” including cybersecurity; training and technical assistance for rural hospitals adopting advanced technologies such as artificial intelligence; behavioral health support, including access to opioid use disorder treatment services; initiatives to foster local and strategic partnerships between providers; and promoting "consumer-facing, technology-driven solutions" for preventing and managing chronic diseases.

“Picture a patient checking symptoms on an iPhone instead of driving 35 miles to the nearest doctor,” CMS Administrator Mehmet Oz, M.D., said of the fund’s tech goals in the announcement video. “Picture an AI-powered system replacing stacks of paperwork, cutting administrative work in half so providers can focus on patients.”

The new notice also outlines specific restrictions for the funding awards. Investments in existing rural care facilities and infrastructure “including minor building alterations or renovations and equipment upgrades” are permitted, but new construction or supplanting other funding for in-process or planned projects are not allowed.

Funds can’t be used to replace or augment clinical service payments reimbursable by insurance or other health coverage, and no clinician salaries or wage support may go to facilities subjecting those clinicians to noncompete agreements.

There is also a 10% cap on funding for direct and indirect administrative purposes, as well as percentage-based limitations around certain electronic health system replacements (maximum 5% of a state’s total awarded funding) and any implementation of a state “Rural Tech Catalyst Fund Initiative” for accelerating health tech adoption (maximum 10%).

“The intent of this funding is not to be used for perpetual operating expenses, but rather for investments that can be made within the duration of the program that will have sustainable impact beyond the end of the program,” the CMS wrote of its spending limitations in the FAQ.

This year’s deadlines are the only opportunity states will have to submit their “bold, audacious proposal ideas as strong as the people they serve,” in the words of the secretary. They will also be required to report on the use of the funds and progress toward any goals annually, as well as to submit annual noncompeting continuation applications to receive subsequent years’ funding.

Though the applications may only be submitted by states, the Notice of Funding Opportunity allows states to “consult and involve numerous partners like universities, local health departments, community-based organizations, and provider associations in designing and implementing the planned activities proposed in your application and may sub-award or contract [Rural Health Transformation] Program funds to such partners for various activities.”

The CMS will be hosting two informational webinars for Rural Health Transformation Program applicants on Sept. 19 and Sept. 25. 

Tuesday, November 18, 2025

The Early Diagnosis and Treatment of Alzheimer's Disease



Treatment of Alzheimer's Disease is dependent on the early diagnosis of the disease.  Treatment of Alzheimer's Disease will not reverse it, however the earlier it is diagnosed it will remain stationary.

A key factor will be the early detection of Alzheimer's Disease, possibly with blood testing. Early clinical trials are now in process. 



The main blood test currently used for detecting Alzheimer's disease is the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, which is FDA-approved and designed to aid in the early detection of amyloid plaques associated with Alzheimer's in adults showing signs of cognitive decline. This test measures two proteins (phosphorylated tau pTau217 and beta-amyloid 1-42) in human plasma and calculates their ratio, which is linked to plaque presence in the brain—a hallmark of Alzheimer's disease.​

Key Details
The Lumipulse blood test requires a standard blood draw and examines plasma for a specific protein ratio.​

Another similar blood test, the PrecivityAD2, measures not just the ratio of amyloid beta proteins but also the level of p-tau217, achieving diagnostic accuracy between 88% and 92% in studies.​

Recently, new tests have also become available, like Elecsys pTau181 and others, which detect different phosphorylated tau proteins in blood.​

Clinical Role

These blood tests are major advancements as they are less invasive than cerebrospinal fluid analysis and brain PET scans, which are traditionally used for Alzheimer's diagnosis.​

The tests are recommended for people already exhibiting cognitive symptoms, as an aid alongside neurological exams, imaging, and cognitive assessments.​

Blood tests for Alzheimer's are most accurate when combined with other diagnostic procedures and are not stand-alone definitive diagnostics yet.​

The global incidence of Alzheimer's disease has continued to rise over the past decade, with an estimated 9.8 million new cases reported globally in 2021, up from approximately 7.2 million cases in 2019. In the United States, the annual number of new Alzheimer's cases has reached about 900,000 people aged 65 or older, with prevalence increasing from 6.7 million affected seniors in 2021 to 7.2 million in 2025.​

Global Trends
Worldwide, the incidence and prevalence of Alzheimer's and other dementias increased by nearly 150% between 1990 and 2019, with the case count nearly doubling every 20 years.​

The annual global estimate for new dementia cases, mostly due to Alzheimer's, is close to 10 million, with projections indicating rapid continued growth as populations age.​

United States Incidence
Each year, approximately 900,000 people aged 65 and older develop Alzheimer's.​

In 2025, 7.2 million Americans aged 65 and older are living with the disease, up from 6.7 million in 2021, and the country expects cases to reach nearly 13 million by 2050.​

The chance of developing Alzheimer's after age 65 is about 1 in 9, and the lifetime risk is around 1 in 5 for women and 1 in 10 for men.​

Changes Over the Past Decade
From 2015 to 2019, some places (like China) saw a slight decline in Alzheimer's incidence, but this was followed by a sharp uptick after 2019, influenced by factors such as aging populations and the COVID-19 pandemic’s impact on vulnerable individuals.​

In Europe and North America, some studies have observed a modest decline (about 13% per decade) in dementia incidence rates, potentially due to public health improvements, though absolute case numbers continue to rise with the aging population.​

COVID-19 contributed to an approximately 10.5% temporary increase in Alzheimer's and dementia deaths in 2020, with elevated risks persisting into 2021.​

Alzheimer's disease is a public health challenge, not only with a decrease in quality of life, a burden on family support, and an increase in medical spending as Boomer's age. The treatment of other causes of death (heart disease, cancer) means people live to be older.  As medical resources become relatively less it wouod be beneficial to diagnose and treat early Alzheimer's

PHYSICIANS MUST BE EDUCATED TO PERFORM THESE TEST WHEN A PATIENT EXHIBITS COGNITIVE DECLINE, NO MATTER WHAT AGE.

Survival

We talk a lot about fixing healthcare, but none of it matters if the people delivering care cannot survive the system themselves. More than ...